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We were interested to read the recent publication
in CMI concerning the role of superantigenic
strains in the prognosis of infections caused by
community-acquired methicillin-susceptible
Staphylococcus aureus (CA-MSSA) [1]. The authors
reported that 73% of CA-MSSA isolates, recov-
ered from 37 immunocompetent patients with
CA-MSSA, produced at least one superantigen,
but that carriage of superantigens by S. aureus did
not affect mortality. We wish to report similar
findings concerning the relationship between
virulence genes carried by methicillin-resistant
S. aureus (MRSA) and the potential for invasive
infection.
We determined the occurrence of 18 virulence
determinants (including adhesins and toxins)
among 26 invasive and 20 colonising isolates of
MRSA, using six separate multiplex PCRs [2–6].
Invasive isolates were recovered over a 3-year
period from patients with device-related bactera-
emia as part of a previous study [7]. Colonising
isolates were from nasal swabs, collected from
patients who were MRSA-positive on their first
admission to the hospital, but who had no
apparent infection.
The distribution of toxin genes was reported to
be similar in MSSA survivors and non-survivors
[1]; similarly, we found no significant correlation
between the carriage of almost all the virulence
genes and the invasiveness of MRSA isolates
(Table 1). The only exception was a significantly
greater frequency of the seg gene in colonising
isolates compared with invasive isolates (100%
and 73%, respectively; p 0.028 by Fisher’s exact
test). The seh gene was harboured by 5% of
colonising isolates and 19.2% of invasive isolates,
but this difference was not statistically significant
(p 0.212). Nashev et al. [8] also reported an
increased frequency of seg among colonising
isolates compared with invasive isolates of MSSA
(73% and 52% [8]) and an increased frequency of
seh in invasive isolates (6.7% vs. 21.4%), but
Desachy et al. [1] reported no difference in the
distribution of these genes. Our study suggested
some variability of the egc cluster, as isolates
positive for sei were not always positive for seg.
Therefore, the presence of one or two egc genes
may not indicate the presence of the entire egc
cluster, as suggested by Desachy et al. [1]. The
absence of an association between these genes
and invasive isolates in our study parallels the
absence of a significant role for superantigens in
the prognosis of patients with sepsis caused by
S. aureus [1].
Characterisation of potential virulence features
of MRSA that are of relevance for pathogenicity in
hospital settings has been the subject of several
recent studies [1,8–10]. As highlighted by previ-
ous studies [1,8–10] and the present findings, the
inability to find a definitive correlation between
invasive S. aureus strains and the carriage of
virulence genes suggests that either the expres-
sion of virulence determinants in vivo mediates
pathogenicity, or that host immune factors may
play a significant role in outcome. The mechanism
by which compromised immunity facilitates
S. aureus infection is probably complex, and is
likely to involve several different aspects of innate
immunity, e.g., compromised neutrophil function,
variations in cytokine or antimicrobial peptide
expression, and the possible involvement of some
components of acquired immunity. The elucida-
tion of these mechanisms in patients who are
colonised or infected with MRSA will contribute
to our understanding of the complexities of
S. aureus pathogenesis.
Table 1. Prevalence of 18 virulence determinants among
colonising and invasive isolates of methicillin-resistant
Staphylococcus aureus
Gene
Prevalence of virulence gene (%)
Colonising isolates (n = 20) Invasive isolates (n = 26)
sea 100 100
seb 0 0
sec 100 100
sed 0 0
see 0 0
seg 100 73
she 5 19.2
sei 100 100
sej 0 0
sek 0 0
seq 0 0
lukPV 0 0
hlg 100 100
tst 20 19.2
can 100 100
fnbA 90 100
sdrE. 100 100
ica 100 100
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Erythromycin-heteroresistant methicillin-
resistant Staphylococcus aureus isolates
from Turkey
10.1111/j.1469-0691.2008.02004.x
We read with interest the Editorial in CMI [1]
concerning the heteroresistance of organisms such
as Staphylococcus aureus, coagulase-negative
staphylococci, Acinetobacter baumannii, Mycobacte-
rium tuberculosis, Streptococcus pneumoniae, Entero-
coccus faecium and Cryptococcus neoformans. The
Editorial focused especially on heteroresistant
vancomycin-intermediate S. aureus and heterore-
sistant glycopeptide-intermediate S. aureus
strains. We would like to draw attention to
another heteroresistance phenomenon that we
observed among methicillin-resistant S. aureus
(MRSA) isolates in Turkiye Yuksek Ihtisas
Teaching and Research Hospital, Ankara, Turkey
[2].
MRSA isolates from various clinical samples
obtained from hospitalised patients at Turkiye
Yuksek Ihtisas Teaching and Research Hospital
were identified by Gram’s stain, tube coagulase
tests and oxacillin agar screening tests. Erythro-
mycin heteroresistance was determined using a
standard disk method [3]. After realising that tiny
colonies grew in the erythromycin inhibition
zone, we decided to test the effect of this hetero-
resistance on the expression of inducible clinda-
mycin resistance using D-tests [4]. In brief, a 15-lg
erythromycin disk was placed 15 mm from the
centre of a 2-lg clindamycin disk. Inhibition of the
circular zone around the clindamycin disk (i.e.,
flattening of the zone towards the erythromycin
disk) was considered to be a positive indication of
inducible clindamycin resistance.
The results of detailed studies with these
erythromycin-heteroresistant isolates were as
follows: (i) colonies growing within the erythro-
mycin inhibition zones were so tiny and so few
in number that they were hardly visible after
incubation for 24 h at 37C, and the isolate could
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